vs
Assertio Holdings, Inc.（ASRT）与Finward Bancorp（FNWD）财务数据对比。点击上方公司名可切换其他公司
Finward Bancorp的季度营收约是Assertio Holdings, Inc.的1.2倍（$16.5M vs $13.5M），Finward Bancorp同比增速更快（1.1% vs -57.9%），过去两年Finward Bancorp的营收复合增速更高（-19.1% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
Finward Bancorp是一家总部位于美国的区域性银行控股公司，主要面向本土运营区域内的个人消费者与中小企业，提供储蓄账户、各类贷款、商业融资及财富管理等零售与商业金融服务。
ASRT vs FNWD — 直观对比
营收规模更大
FNWD
是对方的1.2倍
$13.5M
营收增速更快
FNWD
高出59.0%
-57.9%
两年增速更快
FNWD
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $16.5M |
| 净利润 | — | $2.0M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | 11.0% |
| 净利率 | — | 12.0% |
| 营收同比 | -57.9% | 1.1% |
| 净利润同比 | — | -5.6% |
| 每股收益（稀释后） | $-4.54 | $0.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTFNWD
| Q4 25 | $13.5M | $16.5M | ||
| Q3 25 | $49.5M | $17.4M | ||
| Q2 25 | $29.2M | $16.6M | ||
| Q1 25 | $26.5M | $15.5M | ||
| Q4 24 | $32.2M | $16.3M | ||
| Q3 24 | $29.2M | $14.9M | ||
| Q2 24 | $31.1M | $14.6M | ||
| Q1 24 | $32.4M | $25.3M |
净利润ASRTFNWD
| Q4 25 | — | $2.0M | ||
| Q3 25 | $11.4M | $3.5M | ||
| Q2 25 | $-16.4M | $2.2M | ||
| Q1 25 | $-13.5M | $455.0K | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | $-2.9M | $606.0K | ||
| Q2 24 | $-3.7M | $143.0K | ||
| Q1 24 | $-4.5M | $9.3M |
营业利润率ASRTFNWD
| Q4 25 | -86.7% | 11.0% | ||
| Q3 25 | 23.2% | 20.5% | ||
| Q2 25 | -27.5% | 12.7% | ||
| Q1 25 | -50.0% | 4.0% | ||
| Q4 24 | -41.9% | 16.3% | ||
| Q3 24 | -10.4% | 2.7% | ||
| Q2 24 | -11.6% | 0.9% | ||
| Q1 24 | -13.4% | 40.6% |
净利率ASRTFNWD
| Q4 25 | — | 12.0% | ||
| Q3 25 | 23.1% | 20.1% | ||
| Q2 25 | -56.0% | 12.9% | ||
| Q1 25 | -51.1% | 2.9% | ||
| Q4 24 | — | 12.9% | ||
| Q3 24 | -10.0% | 4.1% | ||
| Q2 24 | -11.8% | 1.0% | ||
| Q1 24 | -13.9% | 36.7% |
每股收益（稀释后）ASRTFNWD
| Q4 25 | $-4.54 | $0.46 | ||
| Q3 25 | $0.11 | $0.81 | ||
| Q2 25 | $-0.17 | $0.50 | ||
| Q1 25 | $-0.14 | $0.11 | ||
| Q4 24 | $-3.28 | $0.50 | ||
| Q3 24 | $-0.03 | $0.14 | ||
| Q2 24 | $-0.04 | $0.03 | ||
| Q1 24 | $-0.05 | $2.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $174.7M |
| 总资产 | $267.0M | $2.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTFNWD
| Q4 25 | $63.4M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $98.2M | — | ||
| Q1 25 | $87.3M | — | ||
| Q4 24 | $100.1M | — | ||
| Q3 24 | $88.6M | — | ||
| Q2 24 | $88.4M | — | ||
| Q1 24 | $80.7M | — |
总债务ASRTFNWD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTFNWD
| Q4 25 | $94.0M | $174.7M | ||
| Q3 25 | $105.8M | $165.5M | ||
| Q2 25 | $93.3M | $154.3M | ||
| Q1 25 | $108.5M | $151.8M | ||
| Q4 24 | $121.1M | $151.4M | ||
| Q3 24 | $130.5M | $159.6M | ||
| Q2 24 | $132.2M | $148.6M | ||
| Q1 24 | $134.5M | $151.6M |
总资产ASRTFNWD
| Q4 25 | $267.0M | $2.0B | ||
| Q3 25 | $319.8M | $2.1B | ||
| Q2 25 | $273.8M | $2.1B | ||
| Q1 25 | $286.4M | $2.0B | ||
| Q4 24 | $284.7M | $2.1B | ||
| Q3 24 | $276.0M | $2.1B | ||
| Q2 24 | $279.4M | $2.1B | ||
| Q1 24 | $282.0M | $2.1B |
负债/权益比ASRTFNWD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $9.9M |
| 自由现金流经营现金流 - 资本支出 | — | $9.0M |
| 自由现金流率自由现金流/营收 | — | 54.8% |
| 资本支出强度资本支出/营收 | — | 5.2% |
| 现金转化率经营现金流/净利润 | — | 4.99× |
| 过去12个月自由现金流最近4个季度 | — | $10.6M |
8季度趋势，按日历期对齐
经营现金流ASRTFNWD
| Q4 25 | $-30.0M | $9.9M | ||
| Q3 25 | $-4.8M | $1.2M | ||
| Q2 25 | $19.1M | $4.8M | ||
| Q1 25 | $-12.5M | $-3.8M | ||
| Q4 24 | $11.5M | $9.8M | ||
| Q3 24 | $-35.0K | $-3.7M | ||
| Q2 24 | $7.4M | $2.8M | ||
| Q1 24 | $7.5M | $-25.0K |
自由现金流ASRTFNWD
| Q4 25 | — | $9.0M | ||
| Q3 25 | — | $1.0M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $-4.0M | ||
| Q4 24 | — | $6.7M | ||
| Q3 24 | — | $-4.2M | ||
| Q2 24 | — | $1.1M | ||
| Q1 24 | — | $-736.0K |
自由现金流率ASRTFNWD
| Q4 25 | — | 54.8% | ||
| Q3 25 | — | 6.0% | ||
| Q2 25 | — | 27.0% | ||
| Q1 25 | — | -25.7% | ||
| Q4 24 | — | 41.2% | ||
| Q3 24 | — | -28.5% | ||
| Q2 24 | — | 7.6% | ||
| Q1 24 | — | -2.9% |
资本支出强度ASRTFNWD
| Q4 25 | — | 5.2% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 18.8% | ||
| Q3 24 | 0.0% | 3.4% | ||
| Q2 24 | — | 11.2% | ||
| Q1 24 | — | 2.8% |
现金转化率ASRTFNWD
| Q4 25 | — | 4.99× | ||
| Q3 25 | -0.42× | 0.34× | ||
| Q2 25 | — | 2.22× | ||
| Q1 25 | — | -8.37× | ||
| Q4 24 | — | 4.66× | ||
| Q3 24 | — | -6.15× | ||
| Q2 24 | — | 19.23× | ||
| Q1 24 | — | -0.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
FNWD
暂无分部数据
